The FDA's Breakthrough Device Designation recognizes Phantom Neuro's potential to provide significant advantages over existing solutions for individuals with function-limiting injuries. The TAP ...
AUSTIN, Texas, March 6, 2025 /PRNewswire/ -- Phantom Neuro, the neurotech company advancing human-machine interface, announces today that it has received two prestigious designations from the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results